CYP3A4 and non-alcoholic fatty liver: Hepatic mRNA VDR levels and the expression of genes downstream the VDR-D pathway [cytochrome P450 (CYP) 2R1, CYP27A1, and CYP3A4] were also increased in patients with nonalcoholic fatty liver (NAFL) compared to healthy individuals [65].